SCHEMBL10120101

SCHEMBL10120101

O=C(CNc1c(-c2ccc3c(c2)CCN3)nc2cnccn12)N1CCN(c2c(Cl)cncc2Cl)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.44
GAA P10253 4/20 0.44
ALDH1A1 P00352 3/20 0.44
HPGD P15428 3/20 0.44
CASP1 P29466 3/20 0.44
CASP7 P55210 3/20 0.44
HSD17B10 Q99714 2/20 0.44
ALOX15 P16050 1/20 0.40
BRD4 O60885 2/20 0.37
SLC2A1 P11166 1/20 0.37
MAPT P10636 2/20 0.37
GFER P55789 1/20 0.37
PLAU P00749 1/20 0.37
PIM1 P11309 1/20 0.36
AURKB Q96GD4 1/20 0.36
ALOX5 P09917 1/20 0.36
TLR9 Q9NR96 2/20 0.36
IDE P14735 1/20 0.36
ATM Q13315 4/20 0.36
ADORA2A P29274 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10120102 0.84 GAA (0.44) KDM4EGAAALDH1A1HPGDCASP1
SCHEMBL15179285 0.84 GAA (0.46) KDM4EGAAALDH1A1HPGDCASP1
SCHEMBL14963797 0.84 GAA (0.57) KDM4EGAAALDH1A1HPGDCASP1
SCHEMBL14963861 0.84 GAA (0.50) KDM4EGAAALDH1A1HPGDCASP1
SCHEMBL10120321 0.84 GAA (0.43) KDM4EGAAALDH1A1HPGDCASP1
SCHEMBL15179298 0.83 GAA (0.48) KDM4EGAAALDH1A1HPGDCASP1
SCHEMBL15179381 0.83 GAA (0.45) KDM4EGAAALDH1A1HPGDCASP1
SCHEMBL10120318 0.83 GAA (0.45) KDM4EGAAALDH1A1HPGDCASP1
SCHEMBL10120306 0.83 GAA (0.42) KDM4EGAAALDH1A1HPGDCASP1
SCHEMBL10048858 0.83 GAA (0.49) KDM4EGAAALDH1A1HPGDCASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012018662-A2 FUSED-IMIDAZOYL COMPOUNDS USEFUL AS ANTIMICROBIAL AGENTS SCHERING CORPORATION (US) 2012-02-09 WO disclosed